Ratio of observed to expected major adverse events (MAE) among patients undergoing congenital cardiac catheterization, risk-adjusted using the Catheterization for Congenital Heart Disease Adjustment for Risk Method II (CHARM II).
Number of diagnostic and interventional cardiac catheterization cases resulting in a major adverse event at an institution performing at least 50 catheterization cases per year meeting the definition of a case type for case type risk categorization in patients with congenital heart disease.
Denominator
1.15 Denominator
Number of diagnostic and interventional cardiac catheterization cases at an institution performing at least 50 cases per year meeting the definition of a case type for case type risk categorization in patients with congenital heart disease.
Exclusions
Exclusions
The following procedures are excluded: primary electrophysiology cases, ablation cases, pericardiocentesis only, thoracentesis only, and any procedure not performed in the catheterization laboratory, such as a case performed in an intensive care unit. In addition, cases without an assigned case type risk category are excluded.
Measure Record
Most Recent Endorsement Activity
Measure Retired and Endorsement Removed Cardiovascular Spring Cycle 2020
Public Comments